SEC Filing Summary for Darren Sherman - Orchestra BioMed Holdings, Inc.

This filing details a transaction by Darren Sherman, President and Chief Operating Officer of Orchestra BioMed Holdings, Inc. On May 28, 2026, Mr. Sherman was involved in a transaction code "F" concerning 4,925 shares of common stock. The transaction involved the disposal of shares with a price of $3.98 per share, resulting in a post-transaction ownership of 1,199,327 shares. This transaction is related to the withholding of shares by the Issuer to satisfy tax obligations in connection with the vesting of restricted stock units (RSUs). No shares were sold on the market. The filing is Form 4, indicating a change in beneficial ownership.